Industry Research Reports
Global Hemostats Market Research Report 2025
Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 106 Pages
Report ld: 3466438
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 4,570
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,240 million
Market Forecast in 2031(Value)
US$ 4,570 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats.
The Hemostats market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemostats market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostats manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Segment by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segment by Application
Prehospital Treatment
Hospital Treatment
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hemostats Market Overview
1.1 Product Definition
1.2 Hemostats by Type
1.2.1 Global Hemostats Market Value Comparison by Type (2024 VS 2031)
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Hemostats by Application
1.3.1 Global Hemostats Market Value by Application (2024 VS 2031)
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Global Hemostats Market Size Estimates and Forecasts
1.4.1 Global Hemostats Revenue 2020-2031
1.4.2 Global Hemostats Sales 2020-2031
1.4.3 Global Hemostats Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemostats Market Competition by Manufacturers
2.1 Global Hemostats Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemostats Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemostats Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemostats, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostats, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostats, Product Type & Application
2.7 Global Key Manufacturers of Hemostats, Date of Enter into This Industry
2.8 Global Hemostats Market Competitive Situation and Trends
2.8.1 Global Hemostats Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemostats Players Market Share by Revenue
2.8.3 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostats Market Scenario by Region
3.1 Global Hemostats Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemostats Sales by Region: 2020-2031
3.2.1 Global Hemostats Sales by Region: 2020-2025
3.2.2 Global Hemostats Sales by Region: 2026-2031
3.3 Global Hemostats Revenue by Region: 2020-2031
3.3.1 Global Hemostats Revenue by Region: 2020-2025
3.3.2 Global Hemostats Revenue by Region: 2026-2031
3.4 North America Hemostats Market Facts & Figures by Country
3.4.1 North America Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemostats Sales by Country (2020-2031)
3.4.3 North America Hemostats Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostats Market Facts & Figures by Country
3.5.1 Europe Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemostats Sales by Country (2020-2031)
3.5.3 Europe Hemostats Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostats Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostats Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemostats Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemostats Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostats Market Facts & Figures by Country
3.7.1 Latin America Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemostats Sales by Country (2020-2031)
3.7.3 Latin America Hemostats Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostats Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostats Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemostats Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemostats Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostats Sales by Type (2020-2031)
4.1.1 Global Hemostats Sales by Type (2020-2025)
4.1.2 Global Hemostats Sales by Type (2026-2031)
4.1.3 Global Hemostats Sales Market Share by Type (2020-2031)
4.2 Global Hemostats Revenue by Type (2020-2031)
4.2.1 Global Hemostats Revenue by Type (2020-2025)
4.2.2 Global Hemostats Revenue by Type (2026-2031)
4.2.3 Global Hemostats Revenue Market Share by Type (2020-2031)
4.3 Global Hemostats Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemostats Sales by Application (2020-2031)
5.1.1 Global Hemostats Sales by Application (2020-2025)
5.1.2 Global Hemostats Sales by Application (2026-2031)
5.1.3 Global Hemostats Sales Market Share by Application (2020-2031)
5.2 Global Hemostats Revenue by Application (2020-2031)
5.2.1 Global Hemostats Revenue by Application (2020-2025)
5.2.2 Global Hemostats Revenue by Application (2026-2031)
5.2.3 Global Hemostats Revenue Market Share by Application (2020-2031)
5.3 Global Hemostats Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Company Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ethicon Hemostats Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Hemostats Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International Inc.
6.3.1 Baxter International Inc. Company Information
6.3.2 Baxter International Inc. Description and Business Overview
6.3.3 Baxter International Inc. Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter International Inc. Hemostats Product Portfolio
6.3.5 Baxter International Inc. Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Company Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.4.4 C. R. Bard Hemostats Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Company Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.5.4 The Medicines Company Hemostats Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Company Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anika Therapeutics Hemostats Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.7.1 Advanced Medical Solutions Company Information
6.7.2 Advanced Medical Solutions Description and Business Overview
6.7.3 Advanced Medical Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Advanced Medical Solutions Hemostats Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences Corporation
6.8.1 Integra LifeSciences Corporation Company Information
6.8.2 Integra LifeSciences Corporation Description and Business Overview
6.8.3 Integra LifeSciences Corporation Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
6.8.5 Integra LifeSciences Corporation Recent Developments/Updates
6.9 B Braun Melsungen AG
6.9.1 B Braun Melsungen AG Company Information
6.9.2 B Braun Melsungen AG Description and Business Overview
6.9.3 B Braun Melsungen AG Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.9.4 B Braun Melsungen AG Hemostats Product Portfolio
6.9.5 B Braun Melsungen AG Recent Developments/Updates
6.10 Gelita Medical GmbH
6.10.1 Gelita Medical GmbH Company Information
6.10.2 Gelita Medical GmbH Description and Business Overview
6.10.3 Gelita Medical GmbH Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Gelita Medical GmbH Hemostats Product Portfolio
6.10.5 Gelita Medical GmbH Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Company Information
6.11.2 Equimedical Description and Business Overview
6.11.3 Equimedical Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Equimedical Hemostats Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Company Information
6.12.2 Vascular Solutions Description and Business Overview
6.12.3 Vascular Solutions Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vascular Solutions Hemostats Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Company Information
6.13.2 Marine Polymer Technologies Description and Business Overview
6.13.3 Marine Polymer Technologies Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Marine Polymer Technologies Hemostats Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
6.14 Z-Medica, LLC
6.14.1 Z-Medica, LLC Company Information
6.14.2 Z-Medica, LLC Description and Business Overview
6.14.3 Z-Medica, LLC Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Z-Medica, LLC Hemostats Product Portfolio
6.14.5 Z-Medica, LLC Recent Developments/Updates
6.15 CryoLife
6.15.1 CryoLife Company Information
6.15.2 CryoLife Description and Business Overview
6.15.3 CryoLife Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CryoLife Hemostats Product Portfolio
6.15.5 CryoLife Recent Developments/Updates
6.16 BioCer Entwicklungs-GmbH.
6.16.1 BioCer Entwicklungs-GmbH. Company Information
6.16.2 BioCer Entwicklungs-GmbH. Description and Business Overview
6.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
6.16.5 BioCer Entwicklungs-GmbH. Recent Developments/Updates
6.17 Biom'Up SAS
6.17.1 Biom'Up SAS Company Information
6.17.2 Biom'Up SAS Description and Business Overview
6.17.3 Biom'Up SAS Hemostats Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Biom'Up SAS Hemostats Product Portfolio
6.17.5 Biom'Up SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostats Industry Chain Analysis
7.2 Hemostats Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostats Production Mode & Process Analysis
7.4 Hemostats Sales and Marketing
7.4.1 Hemostats Sales Channels
7.4.2 Hemostats Distributors
7.5 Hemostats Customer Analysis
8 Hemostats Market Dynamics
8.1 Hemostats Industry Trends
8.2 Hemostats Market Drivers
8.3 Hemostats Market Challenges
8.4 Hemostats Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Hemostats Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Hemostats Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hemostats Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Hemostats Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Hemostats Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Hemostats Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Hemostats Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Hemostats, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemostats, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemostats, Product Type & Application
Table 12. Global Key Manufacturers of Hemostats, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostats Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Hemostats Sales Market Share by Region (2020-2025)
Table 19. Global Hemostats Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Hemostats Sales Market Share by Region (2026-2031)
Table 21. Global Hemostats Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Hemostats Revenue Market Share by Region (2020-2025)
Table 23. Global Hemostats Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Hemostats Revenue Market Share by Region (2026-2031)
Table 25. North America Hemostats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Hemostats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Hemostats Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Hemostats Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Hemostats Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Hemostats Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Hemostats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Hemostats Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Hemostats Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Hemostats Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Hemostats Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Hemostats Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Hemostats Sales (K Pcs) by Type (2020-2025)
Table 51. Global Hemostats Sales (K Pcs) by Type (2026-2031)
Table 52. Global Hemostats Sales Market Share by Type (2020-2025)
Table 53. Global Hemostats Sales Market Share by Type (2026-2031)
Table 54. Global Hemostats Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Hemostats Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Hemostats Revenue Market Share by Type (2020-2025)
Table 57. Global Hemostats Revenue Market Share by Type (2026-2031)
Table 58. Global Hemostats Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Hemostats Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Hemostats Sales (K Pcs) by Application (2020-2025)
Table 61. Global Hemostats Sales (K Pcs) by Application (2026-2031)
Table 62. Global Hemostats Sales Market Share by Application (2020-2025)
Table 63. Global Hemostats Sales Market Share by Application (2026-2031)
Table 64. Global Hemostats Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Hemostats Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Hemostats Revenue Market Share by Application (2020-2025)
Table 67. Global Hemostats Revenue Market Share by Application (2026-2031)
Table 68. Global Hemostats Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Hemostats Price (USD/Pcs) by Application (2026-2031)
Table 70. Ethicon Company Information
Table 71. Ethicon Description and Business Overview
Table 72. Ethicon Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Ethicon Hemostats Product
Table 74. Ethicon Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Pfizer Hemostats Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Baxter International Inc. Company Information
Table 81. Baxter International Inc. Description and Business Overview
Table 82. Baxter International Inc. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Baxter International Inc. Hemostats Product
Table 84. Baxter International Inc. Recent Developments/Updates
Table 85. C. R. Bard Company Information
Table 86. C. R. Bard Description and Business Overview
Table 87. C. R. Bard Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. C. R. Bard Hemostats Product
Table 89. C. R. Bard Recent Developments/Updates
Table 90. The Medicines Company Company Information
Table 91. The Medicines Company Description and Business Overview
Table 92. The Medicines Company Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. The Medicines Company Hemostats Product
Table 94. The Medicines Company Recent Developments/Updates
Table 95. Anika Therapeutics Company Information
Table 96. Anika Therapeutics Description and Business Overview
Table 97. Anika Therapeutics Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Anika Therapeutics Hemostats Product
Table 99. Anika Therapeutics Recent Developments/Updates
Table 100. Advanced Medical Solutions Company Information
Table 101. Advanced Medical Solutions Description and Business Overview
Table 102. Advanced Medical Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Advanced Medical Solutions Hemostats Product
Table 104. Advanced Medical Solutions Recent Developments/Updates
Table 105. Integra LifeSciences Corporation Company Information
Table 106. Integra LifeSciences Corporation Description and Business Overview
Table 107. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Integra LifeSciences Corporation Hemostats Product
Table 109. Integra LifeSciences Corporation Recent Developments/Updates
Table 110. B Braun Melsungen AG Company Information
Table 111. B Braun Melsungen AG Description and Business Overview
Table 112. B Braun Melsungen AG Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. B Braun Melsungen AG Hemostats Product
Table 114. B Braun Melsungen AG Recent Developments/Updates
Table 115. Gelita Medical GmbH Company Information
Table 116. Gelita Medical GmbH Description and Business Overview
Table 117. Gelita Medical GmbH Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Gelita Medical GmbH Hemostats Product
Table 119. Gelita Medical GmbH Recent Developments/Updates
Table 120. Equimedical Company Information
Table 121. Equimedical Description and Business Overview
Table 122. Equimedical Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Equimedical Hemostats Product
Table 124. Equimedical Recent Developments/Updates
Table 125. Vascular Solutions Company Information
Table 126. Vascular Solutions Description and Business Overview
Table 127. Vascular Solutions Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Vascular Solutions Hemostats Product
Table 129. Vascular Solutions Recent Developments/Updates
Table 130. Marine Polymer Technologies Company Information
Table 131. Marine Polymer Technologies Description and Business Overview
Table 132. Marine Polymer Technologies Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Marine Polymer Technologies Hemostats Product
Table 134. Marine Polymer Technologies Recent Developments/Updates
Table 135. Z-Medica, LLC Company Information
Table 136. Z-Medica, LLC Description and Business Overview
Table 137. Z-Medica, LLC Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Z-Medica, LLC Hemostats Product
Table 139. Z-Medica, LLC Recent Developments/Updates
Table 140. CryoLife Company Information
Table 141. CryoLife Description and Business Overview
Table 142. CryoLife Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. CryoLife Hemostats Product
Table 144. CryoLife Recent Developments/Updates
Table 145. BioCer Entwicklungs-GmbH. Company Information
Table 146. BioCer Entwicklungs-GmbH. Description and Business Overview
Table 147. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. BioCer Entwicklungs-GmbH. Hemostats Product
Table 149. BioCer Entwicklungs-GmbH. Recent Developments/Updates
Table 150. Biom'Up SAS Company Information
Table 151. Biom'Up SAS Description and Business Overview
Table 152. Biom'Up SAS Hemostats Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Biom'Up SAS Hemostats Product
Table 154. Biom'Up SAS Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Hemostats Distributors List
Table 158. Hemostats Customers List
Table 159. Hemostats Market Trends
Table 160. Hemostats Market Drivers
Table 161. Hemostats Market Challenges
Table 162. Hemostats Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hemostats
Figure 2. Global Hemostats Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Hemostats Market Share by Type: 2024 & 2031
Figure 4. Thrombin-Based Hemostats Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Combination Hemostats Product Picture
Figure 7. Gelatin Based Hemostats Product Picture
Figure 8. Collagen Based Hemostats Product Picture
Figure 9. Global Hemostats Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Hemostats Market Share by Application: 2024 & 2031
Figure 11. Prehospital Treatment
Figure 12. Hospital Treatment
Figure 13. Global Hemostats Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hemostats Market Size (2020-2031) & (US$ Million)
Figure 15. Global Hemostats Sales (2020-2031) & (K Pcs)
Figure 16. Global Hemostats Average Price (USD/Pcs) & (2020-2031)
Figure 17. Hemostats Report Years Considered
Figure 18. Hemostats Sales Share by Manufacturers in 2024
Figure 19. Global Hemostats Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Hemostats Players: Market Share by Revenue in Hemostats in 2024
Figure 21. Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Hemostats Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Hemostats Sales Market Share by Country (2020-2031)
Figure 24. North America Hemostats Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Hemostats Sales Market Share by Country (2020-2031)
Figure 28. Europe Hemostats Revenue Market Share by Country (2020-2031)
Figure 29. Germany Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Hemostats Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Hemostats Revenue Market Share by Region (2020-2031)
Figure 36. China Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Hemostats Sales Market Share by Country (2020-2031)
Figure 46. Latin America Hemostats Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Hemostats Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Hemostats Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Hemostats Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Hemostats by Type (2020-2031)
Figure 56. Global Revenue Market Share of Hemostats by Type (2020-2031)
Figure 57. Global Hemostats Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Hemostats by Application (2020-2031)
Figure 59. Global Revenue Market Share of Hemostats by Application (2020-2031)
Figure 60. Global Hemostats Price (USD/Pcs) by Application (2020-2031)
Figure 61. Hemostats Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemostats market size from 2025 to 2031?
The annual compound growth rate of the global Hemostats market is 5.9% 2025 to 2031.
Which companies rank high in the global Hemostats market?
What was the global market size of Hemostats in 2025?
Which region is expected to have the highest market share?
What was the global market size of Hemostats in 2031?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now